These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27284048)

  • 1. Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels.
    Wilkinson TC
    Biochem Soc Trans; 2016 Jun; 44(3):831-7. PubMed ID: 27284048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of therapeutic antibodies to G protein-coupled receptors and ion channels: Opportunities, challenges and their therapeutic potential in respiratory diseases.
    Douthwaite JA; Finch DK; Mustelin T; Wilkinson TC
    Pharmacol Ther; 2017 Jan; 169():113-123. PubMed ID: 27153991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of functional antibodies targeting ion channels.
    Wilkinson TC; Gardener MJ; Williams WA
    J Biomol Screen; 2015 Apr; 20(4):454-67. PubMed ID: 25473082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating therapeutic monoclonal antibodies to complex multi-spanning membrane targets: Overcoming the antigen challenge and enabling discovery strategies.
    Dodd R; Schofield DJ; Wilkinson T; Britton ZT
    Methods; 2020 Aug; 180():111-126. PubMed ID: 32422249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies.
    Dodd RB; Wilkinson T; Schofield DJ
    BioDrugs; 2018 Aug; 32(4):339-355. PubMed ID: 29934752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Strategies for the Discovery of Ion Channel Monoclonal Antibodies.
    Colley CS; England E; Linley JE; Wilkinson TCI
    Curr Protoc Pharmacol; 2018 Sep; 82(1):e44. PubMed ID: 30168908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cell-cell interaction format for selection of high-affinity antibodies to membrane proteins.
    Yang Z; Wan Y; Tao P; Qiang M; Dong X; Lin CW; Yang G; Zheng T; Lerner RA
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):14971-14978. PubMed ID: 31285332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels.
    Grigoriadis DE; Hoare SR; Lechner SM; Slee DH; Williams JA
    Neuropsychopharmacology; 2009 Jan; 34(1):106-25. PubMed ID: 18800070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of antibody-based therapeutics targeting G protein-coupled receptors: an update.
    Hutchings CJ
    Expert Opin Biol Ther; 2020 Aug; 20(8):925-935. PubMed ID: 32264722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane protein production and formulation for drug discovery.
    Gulezian E; Crivello C; Bednenko J; Zafra C; Zhang Y; Colussi P; Hussain S
    Trends Pharmacol Sci; 2021 Aug; 42(8):657-674. PubMed ID: 34270922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal Antibodies.
    Simard JR; Michelsen K; Wang Y; Yang C; Youngblood B; Grubinska B; Taborn K; Gillie DJ; Cook K; Chung K; Long AM; Hall BE; Shaffer PL; Foti RS; Gingras J
    J Pharmacol Exp Ther; 2022 Oct; 383(1):56-69. PubMed ID: 35926871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies and venom peptides: new modalities for ion channels.
    Wulff H; Christophersen P; Colussi P; Chandy KG; Yarov-Yarovoy V
    Nat Rev Drug Discov; 2019 May; 18(5):339-357. PubMed ID: 30728472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
    Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
    Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-review: antibody therapeutics targeting G protein-coupled receptors and ion channels.
    Hutchings CJ
    Antib Ther; 2020 Dec; 3(4):257-264. PubMed ID: 33912796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of monoclonal antibodies to neuroscience research.
    Valentino KL; Winter J; Reichardt LF
    Annu Rev Neurosci; 1985; 8():199-232. PubMed ID: 2580471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating ion channel function with antibodies and nanobodies.
    Stortelers C; Pinto-Espinoza C; Van Hoorick D; Koch-Nolte F
    Curr Opin Immunol; 2018 Jun; 52():18-26. PubMed ID: 29579624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting receptor complexes: a new dimension in drug discovery.
    Rosenbaum MI; Clemmensen LS; Bredt DS; Bettler B; Strømgaard K
    Nat Rev Drug Discov; 2020 Dec; 19(12):884-901. PubMed ID: 33177699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic antibodies directed at G protein-coupled receptors.
    Hutchings CJ; Koglin M; Marshall FH
    MAbs; 2010; 2(6):594-606. PubMed ID: 20864805
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.